Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]
Novo Holdings Co-Leads EUR 6M Seed Financing in Asgard Therapeutics
Novo Holdings, a leading international life science investor, today announces that it has co-led the EUR […]
Novo Holdings Co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Novo Holdings, a leading international life science investor, today announces that it has co-led alongside […]
Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today […]
Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings
Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover […]
Novo Holdings Leads Series C in Hummingbird
Novo Holdings today announced that it has led the oversubscribed US$125 million Series C financing in Hummingbird […]
Novo Holdings Participates in US$ 80 Million Series C Investment in Indonesia's Largest Health-tech Platform Halodoc
Novo Holdings today announced that it has joined the US$ 80 million Series C financing in Halodoc, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more